211 related articles for article (PubMed ID: 18093980)
1. Subunit-specific protein footprinting reveals significant structural rearrangements and a role for N-terminal Lys-14 of HIV-1 Integrase during viral DNA binding.
Zhao Z; McKee CJ; Kessl JJ; Santos WL; Daigle JE; Engelman A; Verdine G; Kvaratskhelia M
J Biol Chem; 2008 Feb; 283(9):5632-41. PubMed ID: 18093980
[TBL] [Abstract][Full Text] [Related]
2. Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.
Heuer TS; Brown PO
Biochemistry; 1997 Sep; 36(35):10655-65. PubMed ID: 9271496
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus type 1 integrase: arrangement of protein domains in active cDNA complexes.
Gao K; Butler SL; Bushman F
EMBO J; 2001 Jul; 20(13):3565-76. PubMed ID: 11432843
[TBL] [Abstract][Full Text] [Related]
4. Identification of residues in the C-terminal domain of HIV-1 integrase that mediate binding to the transportin-SR2 protein.
De Houwer S; Demeulemeester J; Thys W; Taltynov O; Zmajkovicova K; Christ F; Debyser Z
J Biol Chem; 2012 Oct; 287(41):34059-68. PubMed ID: 22872638
[TBL] [Abstract][Full Text] [Related]
5. Photo-cross-linking studies suggest a model for the architecture of an active human immunodeficiency virus type 1 integrase-DNA complex.
Heuer TS; Brown PO
Biochemistry; 1998 May; 37(19):6667-78. PubMed ID: 9578550
[TBL] [Abstract][Full Text] [Related]
6. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
7. Divalent cations stimulate preferential recognition of a viral DNA end by HIV-1 integrase.
Yi J; Asante-Appiah E; Skalka AM
Biochemistry; 1999 Jun; 38(26):8458-68. PubMed ID: 10387092
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric analysis of the HIV-1 integrase-pyridoxal 5'-phosphate complex reveals a new binding site for a nucleotide inhibitor.
Williams KL; Zhang Y; Shkriabai N; Karki RG; Nicklaus MC; Kotrikadze N; Hess S; Le Grice SF; Craigie R; Pathak VK; Kvaratskhelia M
J Biol Chem; 2005 Mar; 280(9):7949-55. PubMed ID: 15615720
[TBL] [Abstract][Full Text] [Related]
9. Modeling HIV-1 integrase complexes based on their hydrodynamic properties.
Podtelezhnikov AA; Gao K; Bushman FD; McCammon JA
Biopolymers; 2003 Jan; 68(1):110-20. PubMed ID: 12579583
[TBL] [Abstract][Full Text] [Related]
10. Mode of inhibition of HIV-1 Integrase by a C-terminal domain-specific monoclonal antibody.
Ramcharan J; Colleluori DM; Merkel G; Andrake MD; Skalka AM
Retrovirology; 2006 Jun; 3():34. PubMed ID: 16790058
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 infection requires a functional integrase NLS.
Bouyac-Bertoia M; Dvorin JD; Fouchier RA; Jenkins Y; Meyer BE; Wu LI; Emerman M; Malim MH
Mol Cell; 2001 May; 7(5):1025-35. PubMed ID: 11389849
[TBL] [Abstract][Full Text] [Related]
12. The role of lysine 186 in HIV-1 integrase multimerization.
Berthoux L; Sebastian S; Muesing MA; Luban J
Virology; 2007 Jul; 364(1):227-36. PubMed ID: 17397894
[TBL] [Abstract][Full Text] [Related]
13. Docking dinucleotides to HIV-1 integrase carboxyl-terminal domain to find possible DNA binding sites.
Zhu HM; Chen WZ; Wang CX
Bioorg Med Chem Lett; 2005 Jan; 15(2):475-7. PubMed ID: 15603976
[TBL] [Abstract][Full Text] [Related]
14. Probing HIV-1 integrase inhibitor binding sites with position-specific integrase-DNA cross-linking assays.
Johnson AA; Marchand C; Patil SS; Costi R; Di Santo R; Burke TR; Pommier Y
Mol Pharmacol; 2007 Mar; 71(3):893-901. PubMed ID: 17172465
[TBL] [Abstract][Full Text] [Related]
15. C-Terminal Domain of Integrase Binds between the Two Active Sites.
Roberts VA
J Chem Theory Comput; 2015 Sep; 11(9):4500-11. PubMed ID: 26575940
[TBL] [Abstract][Full Text] [Related]
16. Identification of critical amino acid residues in human immunodeficiency virus type 1 IN required for efficient proviral DNA formation at steps prior to integration in dividing and nondividing cells.
Tsurutani N; Kubo M; Maeda Y; Ohashi T; Yamamoto N; Kannagi M; Masuda T
J Virol; 2000 May; 74(10):4795-806. PubMed ID: 10775618
[TBL] [Abstract][Full Text] [Related]
17. Mapping target site selection for the non-specific nuclease activities of retroviral integrase.
Katzman M; Sudol M; Pufnock JS; Zeto S; Skinner LM
Virus Res; 2000 Jan; 66(1):87-100. PubMed ID: 10653920
[TBL] [Abstract][Full Text] [Related]
18. An unusual helix turn helix motif in the catalytic core of HIV-1 integrase binds viral DNA and LEDGF.
Merad H; Porumb H; Zargarian L; René B; Hobaika Z; Maroun RG; Mauffret O; Fermandjian S
PLoS One; 2009; 4(1):e4081. PubMed ID: 19119323
[TBL] [Abstract][Full Text] [Related]
19. Characterization of recombinant integrase of human immunodeficiency virus type 1 (isolate Bru).
Semenova EA; Gashnikova NM; Il'ina TV; Pronyaeva TR; Pokrovsky AG
Biochemistry (Mosc); 2003 Sep; 68(9):988-93. PubMed ID: 14606941
[TBL] [Abstract][Full Text] [Related]
20. Characterization and structural analysis of HIV-1 integrase conservation.
Ceccherini-Silberstein F; Malet I; D'Arrigo R; Antinori A; Marcelin AG; Perno CF
AIDS Rev; 2009; 11(1):17-29. PubMed ID: 19290031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
